Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 15:15:1367422.
doi: 10.3389/fmicb.2024.1367422. eCollection 2024.

Animal models of Klebsiella pneumoniae mucosal infections

Affiliations
Review

Animal models of Klebsiella pneumoniae mucosal infections

Lucas Assoni et al. Front Microbiol. .

Abstract

Klebsiella pneumoniae is among the most relevant pathogens worldwide, causing high morbidity and mortality, which is worsened by the increasing rates of antibiotic resistance. It is a constituent of the host microbiota of different mucosa, that can invade and cause infections in many different sites. The development of new treatments and prophylaxis against this pathogen rely on animal models to identify potential targets and evaluate the efficacy and possible side effects of therapeutic agents or vaccines. However, the validity of data generated is highly dependable on choosing models that can adequately reproduce the hallmarks of human diseases. The present review summarizes the current knowledge on animal models used to investigate K. pneumoniae infections, with a focus on mucosal sites. The advantages and limitations of each model are discussed and compared; the applications, extrapolations to human subjects and future modifications that can improve the current techniques are also presented. While mice are the most widely used species in K. pneumoniae animal studies, they present limitations such as the natural resistance to the pathogen and difficulties in reproducing the main steps of human mucosal infections. Other models, such as Drosophila melanogaster (fruit fly), Caenorhabditis elegans, Galleria mellonella and Danio rerio (zebrafish), contribute to understanding specific aspects of the infection process, such as bacterial lethality and colonization and innate immune system response, however, they but do not present the immunological complexity of mammals. In conclusion, the choice of the animal model of K. pneumoniae infection will depend mainly on the questions being addressed by the study, while a better understanding of the interplay between bacterial virulence factors and animal host responses will provide a deeper comprehension of the disease process and aid in the development of effective preventive/therapeutic strategies.

Keywords: Klebsiella pneumoniae; animal models; disease pathogenesis; mucosal infection; pre-clinical.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Klebsiella pneumoniae human infection sites and main associated virulence factors. The blue color indicates the infections caused by classical K. pneumoniae strains, while diseases commonly associated with hypervirulent strains are marked in red. This figure was partly generated using templates from Servier Medical Art (Servier), and SlidesGo (Freepik), licensed under a Creative Commons Attribution 3.0 unported license.
Figure 2
Figure 2
Animal models of Klebsiella pneumoniae mucosal infections. The main infection outcomes are shown for each model. The figure was partly generated using Servier Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license. This figure was partly generated using templates from Servier Medical Art (Servier), licensed under a Creative Commons Attribution unported license.

Similar articles

Cited by

References

    1. Aljohani F. S., Rezki N., Aouad M. R., Hagar M., Bakr B. A., Shaaban M. M., et al. . (2022). Novel 1,2,3-Triazole-sulphadiazine-ZnO hybrids as potent antimicrobial agents against Carbapenem resistant Bacteria. Antibiotics (Basel) 11:916. doi: 10.3390/antibiotics11070916 - DOI - PMC - PubMed
    1. Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655. doi: 10.1016/S0140-6736(21)02724-0, PMID: - DOI - PMC - PubMed
    1. Assoni L., Girardello R., Converso T. R., Darrieux M. (2021). Current stage in the development of Klebsiella pneumoniae vaccines. Infect. Dis. Ther. 10, 2157–2175. doi: 10.1007/s40121-021-00533-4, PMID: - DOI - PMC - PubMed
    1. Bachman M. A., Breen P., Deornellas V., Mu Q., Zhao L., Wu W., et al. . (2015). Genome-wide identification of Klebsiella pneumoniae fitness genes during lung infection. MBio 6:e00775. doi: 10.1128/mBio.00775-15, PMID: - DOI - PMC - PubMed
    1. Bakker-Woudenberg I. A., ten Kate M. T., Guo L., Working P., Mouton J. W. (2001). Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats. Antimicrob. Agents Chemother. 45, 1487–1492. doi: 10.1128/AAC.45.5.1487-1492.2001, PMID: - DOI - PMC - PubMed

LinkOut - more resources